Evolving trends in hematopoietic cell transplantation for solid tumors: tempering enthusiasm with clinical reality
Is overall survival a realistic primary end point in advanced colorectal cancer studies? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with CPT-11
Treatment for Waldenstrom's macroglobulinemia
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer
Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection
Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas
Glycemic index, glycemic load and risk of gastric cancer
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter
c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study
Familial risk of endometrial cancer after exclusion of families that fulfilled Amsterdam, Japanese or Bethesda criteria for HNPCC
Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome
Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan
Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey
Use of the WHO lymphoma classification in a population-based epidemiological study
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck
Hematopoetic stem cell transplantation for solid tumors in Europe
5-Fluorouracil induces arterial vasocontractions
A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
Clinical epidemiology of childhood cancer in Central America and Caribbean countries
Age–period–cohort analysis of breast cancer mortality rates in Andalucia (Spain)
With regard to “Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer” by Oh et al. (AnnOnc 2003; 14: 464–569)
With regard to “Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer” by Oh et al. (AnnOnc 2003; 14: 464–569)
Breast conservation in patients of 35 years or younger
Acute dyspnea due to right phrenic palsy during infusional chemotherapy
Extrathymic malignancies in patients with thymoma
Cognitive Behaviour Therapy for People with Cancer